patient assistance News
-
Merck significantly expands its patient assistance program offerings to provide access to more medicines for people in need
Today, Merck announced that it has significantly expanded the number of Merck medicines available through its Merck Helps™ patient assistance programs, which include the Merck Patient Assistance Program, the Merck Vaccine Patient Assistance Program, the ACT Program for Oncology and Hepatitis C medicines, and the SUPPORT Program for HIV/AIDS medicines. The Merck Helps programs provide Merck ...
-
The China Alliance for Rare Diseases (CHARD) and the Chinese Red Cross Foundation (CRCF) jointly initiated the `Rare Disease Mutual Assistance Fund`.
RareStone Group provided the first batch of donations to the foundation. December 18th, during the 2021 China Conference on Rare Diseases in Beijing, the China Alliance for Rare Diseases (CHARD) and the Chinese Red Cross Foundation (CRCF) jointly initiated the "Rare Disease Mutual Assistance Fund." The "Rare Disease Mutual Aid Fund" is dedicated to improving rare disease awareness, ...
-
LifeLink Tissue Bank Announces Partnership with NuTech Spine
LifeLink Tissue Bank, a division of LifeLink Foundation, Inc. headquartered in Tampa, FL, announced a new partnership with NuTech Spine and Biologics, in which NuTech will distribute LifeLink allografts to surgeons nationwide for patients in need of sports, orthopedic and spine transplants. Additionally, LifeLink will process custom spine allografts for distribution. Jean Davis, President and ...
-
Kohl`s unveils exclusive merchandise from Dana Buchman to support women`s health
Kohl's Department Stores (NYSE: KSS) invites customers to join the fight against breast cancer with Kohl's Cares cause merchandise from Dana Buchman. The exclusive cause merchandise, designed to support women's health, is available in all 39 Wisconsin Kohl's stores and online at www.Kohls.com, with 100 percent of the net profit benefitting the fight against breast cancer. The latest collection ...
-
xCures partners with RenovoRx to assist patients in accessing RenovoRx’s TIGeR-PaC study
xCures, Inc. is proud to announce their partnership with RenovoRx, a clinical-stage biopharmaceutical company that focuses on fighting cancer through localized treatment of difficult-to-treat tumors, such as pancreatic adenocarcinoma. Through this collaboration, xCures will help eligible pancreatic cancer patients access a Phase III clinical study entitled, Targeted Intra-arterial Gemcitabine vs. ...
By xCures
-
Kohl`s debuts simply Vera Vera Wang exclusive cause merchandise in support of women`s health
Kohl's Department Stores (NYSE: KSS) invites customers to join the fight against breast cancer through a new Kohl's Cares cause merchandise program designed to support women's health. The company will sell exclusive cause merchandise in all 39 Wisconsin Kohl's stores and online at www.kohls.com, with 100 percent of the net profit donated to support the fight against breast cancer. The first ...
-
National Institute for Health and Care Excellence (NICE) Publishes Briefing on ReStore Soft Exo-Suit in the UK
ReWalk Robotics, Ltd. (Nasdaq: RWLK) ("ReWalk" or the "Company"), a manufacturer of robotic medical devices for individuals with lower limb disabilities, today announced its ReStore Soft Exo-Suit was the subject of a recent Medtech Innovation Briefing (MIB) by the UK's National Institute for Health and Care Excellence (NICE). These briefings are designed to support National Health Services (NHS) ...
-
PhysioAssist and the French CF patient association sign a partnership
PhysioAssist and the French CF patient association ‘Vaincre La Mucoviscidose’ have just signed a partnership to facilitate access to the use of the Simeox device at home. We are delighted about this partnership with the association Vaincre La Mucoviscidose, for allowing an easy access without engagement, as well as financial assistance by the association to the patients who wish to ...
By PhysioAssist
-
atai Life Sciences acquires majority stake in Psyber, Inc., to develop Brain Computer Interface-enabled digital therapeutics targeting mental health disorders
atai Life Sciences ("atai" or the "Company"), a global biopharmaceutical company developing psychedelic and non-psychedelic compounds for various mental health indications, has acquired a majority stake in Delaware based Psyber, a company dedicated to developing interventions to improve various mental health disorders and induce behavioural changes through brain computer interface (BCI)-enabled ...
-
More than 20,000 Novartis associates worldwide to volunteer for local causes in Community Partnership Day
Annual volunteer event to commemorate creation of Novartis in 1996 now benefits hundreds of charities in 55 countries More than 20,000 associates worldwide engage in voluntary activities in their communities Novartis event emphasizes ongoing commitment to Corporate Citizenship Thousands of Novartis associates in 55 countries will engage in volunteer activities to benefit people in their ...
-
More Precise RA Patient Care; New data on the 14-3-3? blood test to help optimize treat-to-target strategies
At the annual European congress of rheumatology meeting, The European League Against Rheumatism (EULAR), taking place in Amsterdam on June 13th-16th, leading investigators from United States, Israel, and Egypt will present new data on the 14-3-3η blood test. Several of these studies grow the body of evidence of 14-3-3η’s key role as an early diagnostic test that assists with ...
-
Medical Microinstruments’ Symani Surgical System Saves Patient’s Arm from Amputation
CALCl, Italy, July 13, 2021- Medical Microinstruments (MMI) SpA, a robotics company dedicated to improving clinical outcomes for patients undergoing microsurgery, announced today that MMI's Symani® Surgical System was successfully used at Careggi University Hospital Florence by Prof. Marco Innocenti and his team in a complex, post-traumatic limb reconstruction that saved a patient's arm from ...
-
Lungpacer Medical, Inc. Announces FDA Approval of Emergency Use Authorization of the Lungpacer Diaphragm Pacing Therapy System to Help Address COVID-19 Pandemic
Lungpacer Medical, Inc., a medical device company developing an intravenous catheter-based phrenic-nerve-pacing system, announced today that the FDA has approved the Emergency Use Authorization for the use of the Lungpacer Diaphragm Pacing Therapy System (DPTS) to assist in weaning patients determined by their healthcare provider to be at high risk of weaning failure. According to the FDA ...
-
GE Capital provides $35 million credit facility to CCS Medical, Inc.
GE Capital, Healthcare Financial Services today announced it has provided a $35 million revolving line of credit to CCS Medical, Inc. The loan will be used to refinance existing debt, provide working capital and support growth initiatives following CCS Medical’s exit from Chapter 11 bankruptcy protection on March 31, 2010. Founded in 1994, CCS Medical is a leading provider of medical supplies ...
-
Notal Vision Monitoring Center Reports AI Analysis of 10 Million ForeseeHome AMD Home Monitoring Tests
Manassas, Virginia (November 30, 2021) - The Notal Vision Monitoring Center celebrates the artificial intelligence (Al) based analysis of the ten millionth test performed by over 20,000 patients with the FDA-cleared ForeseeHome device. The device is part of a comprehensive remote monitoring service for intermediate age-related macular degeneration (AMD) patients at risk of developing the sight ...
-
GERDHelp Mobile App to Assist GERD Patients in Navigating Their Journey With Individualized Education and Support, Provided by EndoGastric Solutions®
REDMOND, Wash – June 23, 2021 – EndoGastric Solutions® today released the GERDHelp™ mobile application that will virtually guide gastroesophageal reflux disease (GERD) sufferers through an individualized treatment pathway providing education and customized support along the patient journey. Patients can easily record GERD-related symptoms, as well as their frequency, ...
-
Dako, an Agilent Technologies Company, and Cell Signaling Technology Announce Partnership Within Companion Diagnostics
Dako, an Agilent Technologies company and a worldwide provider of cancer diagnostics, and Cell Signaling Technology (CST), a worldwide provider of antibodies, today announced that they have entered into a strategic partnership to supply antibodies for use in Dako-branded companion diagnostics products. "We are pleased to work with CST in the development of high-quality, cutting-edge companion ...
-
BioXcel Therapeutics Announces First Patient Dosed in TRANQUILITY II Phase 3 Trial for Acute Treatment of Agitation in Patients with Alzheimer’s Disease
Top-line data for TRANQUILITY II anticipated in Q4 2022/early Q1 2023 Phase 3 TRANQUILITY III study underway with patient enrollment initiating in H2 2022 BioXcel Therapeutics, Inc. (Nasdaq: BTAI), a commercial-stage biopharmaceutical company utilizing artificial intelligence approaches to develop transformative medicines in neuroscience and immuno-oncology, today announced the first ...
-
Sense receives clearance to expand ongoing clinical trial to evaluate non-invasive brain scanner to sites in India and Canada
Clinical trial underway at five US hospital sites to evaluate Sense’s novel, non-invasive brain scanner to monitor intracranial hemorrhage in acute hospital setting Drug Controller General of India (DCGI) and Health Canada grant permission to conduct clinical trial at multiple sites in India and Canada Current standard of care lacks a means to monitor brain injury continuously, ...
-
Corindus Announces New Clinical Data Showing 20 Percent Reduction in Patient Radiation Exposure with Robotic-assisted Intervention
Corindus, a Siemens Healthineers company and leading developer of precision vascular robotics, announced today that Circulation: Cardiovascular Interventions has published clinical results from a comparative study between robotic percutaneous coronary intervention (PCI) and manual PCI. Findings from the study show robotic PCI with the CorPath GRX System reduces patient exposure to radiation by ...
Need help finding the right suppliers? Try XPRT Sourcing. Let the XPRTs do the work for you